Procter & Gamble Hygiene and Health Care Ltd (PGHH) on January 31 reported net profit at Rs 228.9 crore for the December quarter of FY24, registering a growth of 10.32 percent from Rs 207.47 crore in the same quarter of the previous financial year.
The profit growth is led by product price-mix, productivity, and moderating cost inflation versus the base period. The sales of the company was Rs 1131 crore which is at par Y-o-Y.
The company declared an interim dividend of ₹160 per equity share for the financial year 2023-24. (This includes a one-time special dividend of ₹60 per equity share to commemorate its 60th year since commencement of operation)
The Board approved appointment of Dr. Ashima Goyal as Non-executive Independent Director of the Company for a term of five years with effect from March 19, 2024, subject to the approval of the shareholders of the company.
“The quarter has remained challenging amidsta difficult operating environment. We remain committed to our integrated growth strategy of a focused product portfolio of daily use categories where performance drives brand choice, superiority —across product performance, packaging, brand communication, retail execution and consumer and customer value — productivity, constructive disruption, and an agile and accountable organization. We are confident that these strategies will help us navigate the mid-term and deliver balanced growth and value creation." said LV Vaidyanathan, Managing Director.
On January 31, shares of PGHH was trading at 0.09 percent lower at Rs 17149.95 on BSE at 14:05 pm.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
